The antioxidant defense mechanisms, involving key enzymes, such as GR, SOD, and GPx were significantly compromised in both diabetes and DN control groups, as evidenced by a significant reduction in their activity. This evidence concerns the gene SOD1 and liver dysplastic nodule.